222 related articles for article (PubMed ID: 27142288)
1. Gold Complexes for Therapeutic Purposes: an Updated Patent Review (2010-2015).
Nardon C; Pettenuzzo N; Fregona D
Curr Med Chem; 2016; 23(29):3374-3403. PubMed ID: 27142288
[TBL] [Abstract][Full Text] [Related]
2. Density functional theory study of gold(III)-dithiocarbamate complexes with characteristic anticancer potentials.
Lawal MM; Lawal IA; Klink MJ; Tolufashe GF; Ndagi U; Kumalo HM
J Inorg Biochem; 2020 May; 206():111044. PubMed ID: 32120162
[TBL] [Abstract][Full Text] [Related]
3. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.
Feng L; Pomel S; Latre de Late P; Taravaud A; Loiseau PM; Maes L; Cho-Ngwa F; Bulman CA; Fischer C; Sakanari JA; Ziniel PD; Williams DL; Davioud-Charvet E
Molecules; 2020 Nov; 25(21):. PubMed ID: 33139647
[TBL] [Abstract][Full Text] [Related]
4. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases.
Lu Y; Ma X; Chang X; Liang Z; Lv L; Shan M; Lu Q; Wen Z; Gust R; Liu W
Chem Soc Rev; 2022 Jul; 51(13):5518-5556. PubMed ID: 35699475
[TBL] [Abstract][Full Text] [Related]
5. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
[TBL] [Abstract][Full Text] [Related]
6. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
[TBL] [Abstract][Full Text] [Related]
7. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.
Śmiłowicz D; Slootweg JC; Metzler-Nolte N
Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097
[TBL] [Abstract][Full Text] [Related]
8. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents.
García-Moreno E; Tomás A; Atrián-Blasco E; Gascón S; Romanos E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
Dalton Trans; 2016 Feb; 45(6):2462-75. PubMed ID: 26469679
[TBL] [Abstract][Full Text] [Related]
10. Halo and Pseudohalo Gold(I)-NHC Complexes Derived from 4,5-Diarylimidazoles with Excellent
Bian M; Fan R; Jiang G; Wang Y; Lu Y; Liu W
J Med Chem; 2020 Sep; 63(17):9197-9211. PubMed ID: 32787098
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in gold-NHC complexes with biological properties.
Mora M; Gimeno MC; Visbal R
Chem Soc Rev; 2019 Jan; 48(2):447-462. PubMed ID: 30474097
[TBL] [Abstract][Full Text] [Related]
13. Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.
Jurgens S; Kuhn FE; Casini A
Curr Med Chem; 2018 Feb; 25(4):437-461. PubMed ID: 28554319
[TBL] [Abstract][Full Text] [Related]
14. A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes.
Guarra F; Pratesi A; Gabbiani C; Biver T
J Inorg Biochem; 2021 Apr; 217():111355. PubMed ID: 33596529
[TBL] [Abstract][Full Text] [Related]
15. Mononuclear gold(iii) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion.
Warżajtis B; Glišić BĐ; Savić ND; Pavic A; Vojnovic S; Veselinović A; Nikodinovic-Runic J; Rychlewska U; Djuran MI
Dalton Trans; 2017 Feb; 46(8):2594-2608. PubMed ID: 28155927
[TBL] [Abstract][Full Text] [Related]
16. Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.
Rubbiani R; Zehnder TN; Mari C; Blacque O; Venkatesan K; Gasser G
ChemMedChem; 2014 Dec; 9(12):2781-90. PubMed ID: 25377650
[TBL] [Abstract][Full Text] [Related]
17. Proteasome versus Thioredoxin Reductase Competition as Possible Biological Targets in Antitumor Mixed Thiolate-Dithiocarbamate Gold(III) Complexes.
Quero J; Cabello S; Fuertes T; Mármol I; Laplaza R; Polo V; Gimeno MC; Rodriguez-Yoldi MJ; Cerrada E
Inorg Chem; 2018 Sep; 57(17):10832-10845. PubMed ID: 30117739
[TBL] [Abstract][Full Text] [Related]
18. Gold (III) Derivatives in Colon Cancer Treatment.
Gurba A; Taciak P; Sacharczuk M; Młynarczuk-Biały I; Bujalska-Zadrożny M; Fichna J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054907
[TBL] [Abstract][Full Text] [Related]
19. Noble metal-dithiocarbamates precious allies in the fight against cancer.
Nagy EM; Ronconi L; Nardon C; Fregona D
Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
[TBL] [Abstract][Full Text] [Related]
20. Potential Anticancer Activity of Auranofin.
Onodera T; Momose I; Kawada M
Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
